A Look At GE HealthCare (GEHC) Valuation After Weaker Q1 2026 Results And Earnings Guidance Cut

GE HealthCare Technologies (GEHC) is under increased scrutiny after reporting weaker than expected Q1 2026 results and cutting its full year earnings guidance, prompting multiple law firms to open securities investigations.

See our latest analysis for GE HealthCare Technologies.

The share price has been under pressure in recent months, with the 90 day share price return down 23.58% and the year to date share price return down 22.45%, while the 1 year total shareholder return is down 6.96%. This suggests sentiment has weakened despite ongoing product announcements in AI enabled imaging and radiation therapy.

If you are comparing GE HealthCare’s recent volatility with other opportunities in medical technology, this could be a good moment to look at AI focused healthcare peers using the 34 healthcare AI stocks

With the stock down sharply this year and trading below some analyst value estimates, the key question now is simple: are you looking at an undervalued healthcare equipment leader or a stock where the market already prices in future growth?

Most Popular Narrative: 19.7% Undervalued

At a last close of $64.23 versus a narrative fair value of about $79.95, the current pricing sits well below what analysts' models suggest for GE HealthCare.

The pipeline of new high-impact products, like Radiopharmaceuticals, Total Body PET, and Photon Counting CT, is anticipated to drive future revenue growth and potentially improve margins.

Read the complete narrative.

Curious how that product lineup feeds into the $79.95 fair value, a reset discount rate, and a lower future P/E multiple than the wider medical equipment sector.

Result: Fair Value of $79.95 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this narrative could still be knocked off course if tariffs continue to weigh on earnings or if regulatory changes in China pressure that revenue base.

Find out about the key risks to this GE HealthCare Technologies narrative.

Next Steps

With sentiment in this article leaning cautious but not entirely one-sided, it makes sense to review the full picture yourself and then decide how to react to the 4 key rewards and 1 important warning sign

Looking for more investment ideas?

Once you have formed a view on GE HealthCare, do not stop there. Broaden your watchlist with a few focused stock ideas using the Simply Wall Street Screener.

• Target potential mispricings by scanning 48 high quality undervalued stocks that combine quality fundamentals with compressed valuations.
• Prioritise resilience with 69 resilient stocks with low risk scores that score well on financial strength and business stability.
• Get ahead of the crowd by checking the screener containing 21 high quality undiscovered gems that still sit off most investors' radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com